Securing supply for Cagrilintide 10mg and abaloparatide can be challenging, as they are prescription treatments primarily approved for osteoporosis care in patients at increased risk for fractures. Typically, these therapies are not available over-the-top and demand a prescription. A physician is the initial point of contact for determining eligibi